Brendan Technologies CTO to Make Presentation to Regulatory Organization on Drug Release Testing

CARLSBAD, Calif.--(BUSINESS WIRE)--Dr. John Dunn, founder and chief technical officer of Brendan Technologies, Inc. (BDTE.OB, www.brendan.com), an innovative analytical software company, has been invited by the United States Pharmacopeia (USP) to make a presentation at its USP Bioassay Workshop. The event will be held at the USP Headquarters in Rockville, Maryland, August 13 – 14, 2008.
MORE ON THIS TOPIC